Julie Schneider to Middle Aged
This is a "connection" page, showing publications Julie Schneider has written about Middle Aged.
Connection Strength
0.533
-
A novel SNCA E83Q mutation in a case of dementia with Lewy bodies and atypical frontotemporal lobar degeneration. Neuropathology. 2020 Dec; 40(6):620-626.
Score: 0.089
-
Temporal course and pathologic basis of unawareness of memory loss in dementia. Neurology. 2015 Sep 15; 85(11):984-91.
Score: 0.063
-
Elevated neuroinflammation, autoimmunity, and altered IgG glycosylation profile in the cerebral spinal fluid of severe COVID-19 patients. Brain Behav Immun. 2025 Aug; 128:289-302.
Score: 0.031
-
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol. 2022 08; 21(8):714-725.
Score: 0.026
-
To what degree is late life cognitive decline driven by age-related neuropathologies? Brain. 2021 08 17; 144(7):2166-2175.
Score: 0.024
-
A Genetic Study of Cerebral Atherosclerosis Reveals Novel Associations with NTNG1 and CNOT3. Genes (Basel). 2021 05 26; 12(6).
Score: 0.024
-
B and T Lymphocyte Densities Remain Stable With Age in Human Cortex. ASN Neuro. 2021 Jan-Dec; 13:17590914211018117.
Score: 0.023
-
Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun. 2020 02 03; 11(1):667.
Score: 0.022
-
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease. Nat Med. 2020 01; 26(1):131-142.
Score: 0.021
-
Brain Bromine Levels Associated with Alzheimer's Disease Neuropathology. J Alzheimers Dis. 2020; 73(1):327-332.
Score: 0.021
-
Seasonal plasticity of cognition and related biological measures in adults with and without Alzheimer disease: Analysis of multiple cohorts. PLoS Med. 2018 09; 15(9):e1002647.
Score: 0.020
-
Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample. Mol Neurodegener. 2015 Dec 02; 10:65.
Score: 0.016
-
Suprachiasmatic neuron numbers and rest-activity circadian rhythms in older humans. Ann Neurol. 2015 Aug; 78(2):317-22.
Score: 0.016
-
a-Synuclein pathology accumulates in sacral spinal visceral sensory pathways. Ann Neurol. 2015 Jul; 78(1):142-9.
Score: 0.016
-
Residual decline in cognition after adjustment for common neuropathologic conditions. Neuropsychology. 2015 May; 29(3):335-43.
Score: 0.015
-
Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA Neurol. 2014 Nov; 71(11):1394-404.
Score: 0.015
-
Genetic susceptibility for Alzheimer disease neuritic plaque pathology. JAMA Neurol. 2013 Sep 01; 70(9):1150-7.
Score: 0.014
-
The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-e4 carriers. PLoS Genet. 2013; 9(8):e1003685.
Score: 0.014
-
Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology. 2013 Jul 23; 81(4):314-21.
Score: 0.014
-
CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013 Jul; 16(7):848-50.
Score: 0.014
-
APOE e4 increases risk for dementia in pure synucleinopathies. JAMA Neurol. 2013 Feb; 70(2):223-8.
Score: 0.013
-
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-? plaques: a prospective cohort study. Lancet Neurol. 2012 Aug; 11(8):669-78.
Score: 0.013
-
CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol. 2011 Mar; 69(3):560-9.
Score: 0.012